Phenyl alkyl ketones

Synopsis

Phenyl Alkyl Ketones: A Comprehensive Encyclopedic Reference

1. Identity, Chemistry, and Nomenclature

Phenyl alkyl ketones are a structurally diverse class of naturally occurring organic compounds defined by the presence of a phenyl (or substituted aromatic) group covalently bonded to an alkyl chain that bears a ketone (carbonyl, C=O) functional group. They are characterized by the presence of a phenyl group attached to an alkyl ketone structure. Within the broader landscape of plant secondary metabolites, this chemical motif recurs across multiple distinct compound families, ranging from small phenylbutanoids found in common spices to structurally elaborate diarylheptanoids isolated from tropical gingers.

The most pharmacologically and commercially significant natural phenyl alkyl ketones are:

Raspberry ketone (4-(4-hydroxyphenyl)butan-2-one; also known as frambinone or rheosmin): The phenylbutanoid 4-(4-hydroxyphenyl)butan-2-one, commonly known as raspberry ketone, is responsible for the typical scent and flavor of ripe raspberries.
Zingerone (4-(4-hydroxy-3-methoxyphenyl)butan-2-one; also called vanillylacetone): Zingerone is a phenolic alkanone derived from ginger (Zingiber officinale Roscoe), which is known for its antioxidant and anti-inflammatory properties.
Gingerol homologs ([6]-gingerol being the principal form): Gingerol (correctly, [6]-gingerol) is the predominant phenol and most important of the pungent constituents in ginger oil. It was isolated by J. C. Thresh in 1879 from the rhizome of the ginger plant (Zingiber officinale).
Shogaols (dehydrated gingerol derivatives, principally [6]-shogaol): Shogaol and the fragmented molecule zingerone are produced when fresh ginger is heated or cooked.
Diarylheptanoids (including curcumin and related compounds): The diarylheptanoids (also known as diphenylheptanoids) are a class of plant secondary metabolites. Diarylheptanoids consist of two aromatic rings (aryl groups) joined by a seven carbons chain (heptane) and having various substituents.

All of these compounds share the defining structural hallmark of the phenyl alkyl ketone motif: an aromatic ring connected through an aliphatic chain to a ketone group. They differ in chain length, hydroxylation pattern, methoxylation, and degree of unsaturation. The biological effects of ginger constituents include phenolics (gingerols, [6]-shogaol, [6]-paradol and zingerone) and diarylheptanoids (curcumin).

1.1 Diarylheptanoids as a Major Structural Subfamily

Diarylheptanoids constitute a distinct group of natural plant metabolites characterized by two aromatic rings linked by a linear seven-carbon aliphatic chain. They may be divided into two subgroups — open chain and macrocyclic. Research on their phytochemistry and phytoanalysis is rapidly growing and the number of identified structures bearing the aryl-C7-aryl skeleton is at present approaching 500. Historically, the yellow pigment curcumin has been characterized as the first diarylheptanoid and the extensive research on naturally occurring analogues is still ongoing.

They can be classified into linear (curcuminoids) and cyclic diarylheptanoids. The best known member is curcumin, which is isolated from turmeric (Curcuma longa) and is known as food coloring E100.

2. Natural Sources and Botanical Origins

2.1 Raspberry Ketone

Raspberry ketone, a phenylpropanoid-derived compound utilized as a food additive and cosmetics constituent, is a distinctive aromatic component that is accumulated in the ripe fruit of raspberry (Rubus idaeus). Raspberry ketone (RK) is an aromatic phenolic compound naturally occurring in red raspberries, kiwifruit, peaches, and apples and reported for its potential therapeutic and nutraceutical properties. Despite being the defining aromatic molecule of raspberries, the natural concentration of RK in raspberries is not only very low (1–4 mg/kg), but also subject to seasonal and regional fluctuations, leading to high product costs of 3000–20,000 US$ per kg of natural, extracted RK. This volatile compound is also found in several other plant species in an organ-specific manner, such as rhubarb roots, pine needles, and in the orchid Bulbophyllum flowers, while its amount in these species is very low, even from raspberries.

Because of this scarcity, chemical production of nature-identical raspberry ketone is well established as this compound is frequently used to flavor food, beverages and perfumes. The chemical synthesis route proceeds via the aldol condensation of acetone with 4-hydroxybenzaldehyde and subsequent reduction. Biotechnological production routes using engineered microorganisms are also actively researched as alternatives.

2.2 Zingerone, Gingerol, and Shogaol — Ginger (Zingiber officinale)

Ginger (Zingiber officinale Roscoe) belongs to the family Zingiberaceae. Z. officinale is indigenous to tropical Asia, probably to southern China or India. The characteristic odor and flavor of ginger root are due to bioactive components of ginger such as zingerone, shogaols, gingerols, and volatile oils. Gingerols are a group of volatile phenolic compounds that are pungent in nature. 6-Gingerol is the major compound of the rhizome responsible for the pungency, while other gingerols, such as 4-, 8-, 10- and 12-gingerols, are present in lesser concentrations.

The relative composition of these phenyl alkyl ketone constituents depends critically on the form of ginger used. The non-volatile components give ginger a pungent, spicy taste, including gingerol, shogaol, zingerone, and paradol. In fresh ginger, the main component is gingerol, which will then be converted to shogaol, zingerone, and paradol in ginger-based products. More specifically, more than 50 volatile components have been successfully characterized in ginger, including sesquiterpene hydrocarbons consisting of zingiberene, curcumene, and farnesene, while non-volatile components comprise phenolic compounds like gingerols, shogaols, paradols, and zingerone (ZiN), responsible for its pharmacological activities. Interestingly, fresh ginger extracts constitute the latter phytochemicals except ZiN, which forms gradually upon drying or cooking of ginger, reportedly via a retroaldol reaction of gingerol.

2.3 Diarylheptanoids — Broader Plant Families

Diarylheptanoids have been reported from plants in 10 different families, e.g. Betulaceae and Zingiberaceae. Open chain diarylheptanoids were isolated from Acer nicoense (Aceraceae), from Alnus and Betula species (Betulaceae), from Alpinia, Curcuma, and Zingiber species belonging to the family of gingers (Zingiberaceae) and finally from certain Centrolobium species (Leguminosae). Some other Curcuma species, such as Curcuma comosa, also produce diarylheptanoids.

3. Biosynthesis in Plants

The biosynthetic origin of phenyl alkyl ketones in plants traces through the phenylpropanoid pathway — one of the primary routes for aromatic secondary metabolite production across the plant kingdom. The biosynthetic pathway leading to raspberry ketone production shares a common metabolic pathway with anthocyanin pigments, branching from p-coumaroyl-CoA, which is biosynthesized via the general phenylpropanoid pathway from phenylalanine by phenylalanine ammonia-lyase (PAL), cinnamate 4-hydroxylase (C4H), and 4-coumarate-CoA ligase (4CL).

For diarylheptanoids, the proposed biosynthetic journey begins with the amino acid L-phenylalanine. Through a series of enzymatic reactions involving phenylalanine ammonia-lyase (PAL), cinnamate-4-hydroxylase (C4H), and 4-coumarate:CoA ligase (4CL), L-phenylalanine is converted into p-coumaroyl-CoA. It is hypothesized that the backbone of the diarylheptanoid is assembled by a type III polyketide synthase (PKS). This enzyme would catalyze the condensation of one molecule of p-coumaroyl-CoA with three molecules of malonyl-CoA.

4. Traditional and Historical Use

4.1 Ginger in Ayurvedic Tradition

Zingiber officinale's story spans millennia — first domesticated in Southeast Asia around 5000 BCE. Chinese herbals like the Shen Nong Ben Cao Jing (circa 1st century CE) described "Sheng Jiang" for its digestive and warming functions, while Ayurveda's Charaka Samhita (~2nd century CE) called Shunti a remedy for "ama" (toxins) and Vata imbalances. Traditionally, Ayurveda uses the dried rhizome (Shunti) and fresh rhizome (Ardraka) separately: fresh for digestive upsets, dried for longer shelf life and warming action.

It is used in Ayurvedic medicine for the treatment of different ailments, including headache, pain, respiratory diseases, indigestion, fever, common cold and cough. Ginger's phenyl alkyl ketone-bearing compounds — primarily gingerol, shogaol, and zingerone — are the chemical agents responsible for the pungency and, according to modern chemical analysis, for many of its ascribed pharmacological properties.

4.2 Ginger in Traditional Chinese Medicine (TCM)

TCM philosophy classifies ginger as a warming herb, particularly suitable for conditions characterized by cold or dampness in the body. People commonly use it to treat digestive disorders, colds, arthritis, and various inflammatory conditions. People believe that ginger's warming nature stimulates circulation, dispels cold pathogens, and alleviates stagnation in the body's energy pathways, known as meridians.

4.3 Cross-Cultural Traditional Applications

Ginger is firmly entrenched in culinary and the preferred choice of medical practitioners from time immemorial. This herb plays an important role in Ayurvedic, Chinese, Arabic, and African traditional medicines to treat headaches, nausea, colds, arthritis, rheumatism, muscular discomfort, and inflammation.

Ginger was introduced to Europe via the spice trade routes and became incorporated into medieval European pharmacopeias as a digestive remedy. Ginger (Zingiber officinale Roscoe) has been used as a food, spice, supplement and flavoring agent and in traditional medicines due to its beneficial characteristics such as pungency, aroma, nutrients and pharmacological activity.

Raspberry (Rubus idaeus) itself has a long culinary and modest medicinal history. Raspberry (European red raspberry, Rubus idaeus) is one of the oldest fruits known to people and has been used throughout the centuries for nutritional and medicinal purposes. Like its popular relatives the strawberry and blueberry, raspberry contains an abundance of sugars, vitamins, minerals, and polyphenols. Studies on the biological effects of raspberry components have yielded many results. The specific isolation of raspberry ketone as a defined chemical entity and its investigation as a therapeutic or nutraceutical agent is a modern development rather than a feature of traditional use.

4.4 Curcuma comosa in Southeast Asian Traditional Medicine

The diarylheptanoid-rich plant Curcuma comosa Roxb., a member of the ginger family, has been used in Southeast Asian traditional medicine. Diarylheptanoids isolated from Curcuma comosa Roxb. have been recently identified as phytoestrogens. Its traditional use in Thai folk medicine for gynecological and uterine conditions has provided the context for scientific investigation of its diarylheptanoids as phytoestrogens.

5. Key Constituents and Active Compounds

5.1 Raspberry Ketone (RK)

Raspberry ketone (4-(4-hydroxyphenyl)butan-2-one; CAS 5471-51-2) is a simple phenylbutanoid: a four-carbon chain with a ketone at position 2, bearing a para-hydroxyphenyl group at position 1. Raspberry ketones are structurally similar to capsaicin, a chemical in some peppers, and synephrine, a compound in oranges. This structural kinship with known thermogenic agents has been the primary driver of research interest and commercial marketing of raspberry ketone as a metabolic supplement.

5.2 Gingerol Homologs

Active compounds credibly linked to Zingiber officinale include gingerol, shogaol, and zingerone, along with smaller amounts of paradol, beta-sesquiphellandrene, and zingiberene. The gingerols differ by alkyl chain length, with [6]-gingerol bearing a hexyl side chain and being the most abundant. The major players are gingerols — especially [6]-gingerol — which transform into shogaols (notably [6]-shogaol) when heated or dried. The shogaols bear an α,β-unsaturated ketone moiety, which is considered central to their potent bioactivity. 6-Shogaol has exhibited the most potent antioxidant and anti-inflammatory properties, which can be attributed to the presence of this alpha,beta-unsaturated ketone moiety.

5.3 Zingerone

Zingerone is one of the non-volatile compounds present in ginger. It contains a methoxy phenol group, which consists of a basic phenolic ring with a methoxy group that is attached to a benzene ring. It is commonly formed from gingerol. Zingerone (4-(4-hydroxy-3-methoxyphenyl)butan-2-one) is structurally differentiated from raspberry ketone by the addition of a methoxy group at the meta position of the hydroxyphenyl ring.

5.4 Diarylheptanoids (Curcuminoids and Related)

Diarylheptanoids can be classified into linear (curcuminoids) and cyclic diarylheptanoids. The curcuminoids — curcumin, demethoxycurcumin, and bisdemethoxycurcumin — are the best-characterized members, featuring two phenylpropane units connected by a seven-carbon chain containing one or more ketone groups (in the diketone tautomeric form) or an enol. Among the naturally occurring diarylheptanoids from Curcuma comosa, specific bioactive members include (3S)-1,7-diphenyl-(6E)-6-hepten-3-ol (D1), 1,7-diphenyl-(6E)-6-hepten-3-one (D2), and (3R)-1,7-diphenyl-(4E,6E)-4,6-heptadien-3-ol (D3).

6. Established Mechanisms of Action

6.1 Lipid Metabolism and Adipokine Regulation (Raspberry Ketone)

The primary mechanistic hypothesis for raspberry ketone's metabolic activity centers on two pathways. The exact metabolic action of raspberry ketone is theorized as being twofold. One action is the stimulation of the hormone adiponectin. Adiponectin is a potent enhancer of fatty acid oxidation and glucose regulation, as well as an inhibitor of lipid accumulation. The second mechanism of action is thought to be the stimulation of naturally occurring norepinephrine-mediated lipolysis.

At the cellular level, an in vitro study in adipocytes showed that raspberry ketone increased the oxidation of fatty acids, inhibited lipid accumulation, and increased the secretion of adiponectin. At the molecular level, the underlying mechanism for these biological effects includes decreased expression of transcription factors and genes involved in the adipogenesis process (PPARγ, C/EBPα, ACC, FAS, SCD1), and increased expression of genes involved in the oxidation of fatty acids (HSL, CPT, triglyceride lipase).

Regarding lipolysis specifically: given the structural similarity between RK and synephrine, it has been speculated that RK stimulates lipolysis via the activation of β-adrenergic receptors. However, studies in rats have shown that RK significantly increases the noradrenaline-induced lipolysis, not via HSL activation but by facilitating the translocation of HSL from the cytosol to lipid droplets in rat fat cells.

6.2 Anti-inflammatory Mechanisms (Zingerone and Gingerols)

Cytokine production, MAPK, and NF-κB activation are all inhibited dose-dependently by zingerone. Zingerone also reduces 8-OHdG over-expression in the liver tissue and the expression of NADPH oxidase 4 (NOX4), inflammatory cytokines (e.g., IFN-γ, IL-17, IL-6, COX-2, TNF-α, and iNOS mRNA level), decreases macrophage inflammatory protein cytokines, and eliminates free radicals.

Ginger's antioxidant and anti-inflammatory properties are provided by gingerol, shogaols, paradol, and zingerone. Ginger's antioxidant mechanism is linked to Nrf2 signaling pathway activation. Its anti-inflammatory mechanism is linked to Akt inhibition and NF-κB activation, triggering the release of anti-inflammatory cytokines while reducing proinflammatory cytokines.

For zingerone specifically, it lessens oxidative stress, inflammation, apoptosis, and oxidative DNA damage by increasing the activities of superoxide dismutase (SOD), catalase (CAT), glutathione (GSH), and glutathione peroxidase (GPX).

6.3 AMPK Activation (Zingerone)

Zingerone, a bioactive compound derived from ginger, exhibits a broad spectrum of pharmacological properties including antioxidant, anti-inflammatory, and AMPK-activating activities. Previous studies have demonstrated that zingerone can activate AMPK in different pathological contexts; for example, it was shown to ameliorate non-alcoholic fatty liver disease (NAFLD) in rats through AMPK pathway activation and to protect against vascular calcification via AMPK-dependent signaling.

6.4 Sensory Neuron Activation and IGF-I Induction (Topical Raspberry Ketone)

Sensory neurons release calcitonin gene-related peptide (CGRP) on activation. Topical application of capsaicin increases facial skin elasticity and promotes hair growth by increasing dermal insulin-like growth factor-I (IGF-I) production through activation of sensory neurons. Raspberry ketone has a structure similar to that of capsaicin. Thus, it is possible that RK activates sensory neurons, thereby increasing skin elasticity and promoting hair growth by increasing dermal IGF-I production.

6.5 Phytoestrogenic Activity (Diarylheptanoids from Curcuma comosa)

All diarylheptanoids isolated from Curcuma comosa up-regulated estrogen-responsive genes in estrogen-responsive breast cancer cells (MCF-7). In HepG2 cells transfected with estrogen receptor (ER) β or different ERα functional receptor mutants — indicating estrogen receptor–dependent mechanisms. This positions these compounds as phytoestrogens with potential relevance to hormonal balance, though clinical data are very limited.

6.6 Neuroprotective Mechanisms (Zingerone)

The anti-neuroinflammatory mechanisms of zingerone were linked to the inhibition of nuclear factor kappa B (NF-κB) activation and the NOD-like receptor family, pyrin domain-containing 3 (NLRP3) inflammasome, as well as the reduction in neuronal nitric oxide synthase (nNOS). The anxiolytic and anti-depressive effects of zingerone were also associated with an improvement in cortical cholinergic transmission, the mitigation of oxidative stress and the upregulation of neurotransmitters such as serotonin and dopamine.

7. Scientific Evidence by Area of Use

7.1 Body Weight and Adiposity — Raspberry Ketone

Animal evidence: The foundational in vivo study, published in Life Sciences (2005), was conducted by Morimoto and colleagues. The study was performed to clarify whether RK helps prevent obesity and activate lipid metabolism in rodents. Mice were fed a high-fat diet including 0.5, 1, or 2% of RK for 10 weeks. RK prevented the high-fat-diet-induced elevations in body weight and the weights of the liver and visceral adipose tissues (epididymal, retroperitoneal, and mesenteric). RK also decreased these weights and hepatic triacylglycerol content after they had been increased by a high-fat diet. RK significantly increased norepinephrine-induced lipolysis associated with the translocation of hormone-sensitive lipase from the cytosol to lipid droplets in rat epididymal fat cells. In conclusion, RK prevents and improves obesity and fatty liver. These effects appear to stem from the action of RK in altering the lipid metabolism, or more specifically, in increasing norepinephrine-induced lipolysis in white adipocytes.

A subsequent in vitro study (Park, 2010) in 3T3-L1 adipocytes found that treatment with 10 µM of RK increased lipolysis significantly in differentiated 3T3-L1 cells. An immunoassay showed that RK increased both the expression and the secretion of adiponectin. In addition, treatment with 10 µM of RK increased the fatty acid oxidation and suppressed lipid accumulation in 3T3-L1 adipocytes.

However, one later mouse study found a more ambiguous result: raspberry ketone (RK; 4-(4-hydroxyphenyl)butan-2-one) is a bioactive phytochemical that is marketed as a weight loss supplement in the United States, yet there is scant scientific evidence demonstrating that RK promotes weight loss.

Human / clinical evidence: The only randomized, placebo-controlled, double-blind human study combined raspberry ketone with five other supplements known to enhance weight loss. A total of 45 obese adults completed an eight-week trial of exercise and controlled diet, and, in the test group, supplementation with the raspberry ketone combination. All measurements of body weight in the test group were significantly lower at the end of the study than those of the control group. It is unknown how much of this effect was attributable to the raspberry ketone alone. The multi-ingredient supplement included caffeine anhydrous, bitter orange fruit, ginger root extract, garlic root extract, cayenne extract, L-theanine, and pepper extract alongside raspberry ketone, making it impossible to attribute any observed effect to the ketone independently. More clinical trials with RK as a single supplement should be performed to remove the effect of confounders as well as to determine the best dose of RK for its anti-obesity effects.

Evidence assessment: With regard to human trials, the evidence is scanty and often ambiguous. There were a couple of small clinical studies involving or combining raspberry ketones with other substances (like caffeine or green tea extract), which reported negligible weight loss, but it is still not clear if the ketones played an active role at all. There is no substantial, unbiased clinical evidence that raspberry ketones by themselves lead to the kind of weight loss that is either significant or lasting. The evidence base is currently insufficient to draw conclusions about efficacy in human weight management.

7.2 Hair Growth and Skin Elasticity — Topical Raspberry Ketone

The most substantive human clinical data for raspberry ketone relates to topical, not oral, administration. A 2008 study (Harada et al., published in Growth Hormone & IGF Research) investigated the topical application of a 0.01% RK formulation. RK, at concentrations higher than 1 µM, significantly increased CGRP release from dorsal root ganglion neurons isolated from wild-type mice, and this increase was completely reversed by capsazepine, an inhibitor of vanilloid receptor-1 activation. Topical application of 0.01% RK increased dermal IGF-I levels at 30 min after application in wild-type mice. Topical application of 0.01% RK increased immunohistochemical expression of IGF-I at dermal papillae in hair follicles and promoted hair re-growth in wild-type mice at 4 weeks after the application.

In the human component of the same study: when applied topically to the scalp and facial skin, 0.01% RK promoted hair growth in 50.0% of humans with alopecia (n=10) at 5 months after application and increased cheek skin elasticity at 2 weeks after application in 5 females (p<0.04).

Evidence assessment: This single small human study (n=10 for hair growth) is promising but highly preliminary. The study population was very small, the methodology of the human arm was not detailed as a full randomized controlled trial, and no independent replication has been published. No conclusions regarding clinical efficacy can be drawn from this alone.

7.3 Anti-inflammatory Activity — Zingerone

Preclinical evidence for zingerone's anti-inflammatory activity is well developed, though human trials are absent. In a study comprehensively evaluating the anti-inflammatory activities of ginger and its component zingerone in lipopolysaccharide (LPS)-induced acute systemic inflammation in mice via nuclear factor-κB (NF-κB) bioluminescent imaging, ginger and zingerone significantly suppressed LPS-induced NF-κB activities in cells in a dose-dependent manner, and the maximal inhibition (84.5% ± 3.5% and 96.2% ± 0.6%) was observed at 100 µg/mL ginger and zingerone, respectively. Moreover, dietary ginger and zingerone significantly reduced LPS-induced proinflammatory cytokine production in sera by 62.9% ± 18.2% and 81.3% ± 6.2%, respectively.

In a rat carrageenan-induced inflammation model: zingerone, a bioactive substance derived from ginger root, has a variety of pharmacological properties, such as reducing inflammation and antioxidant effects. In a carrageenan-induced inflammation model, paw edema induced by carrageenan (100 µl of 1%) was used to induce acute inflammation in rats. Different doses of zingerone (10, 20, and 40 mg/kg) were administered intraperitoneally. Results showed that zingerone, especially at the highest dose of 40 mg/kg, significantly reduced paw swelling in carrageenan-injected animals.

Evidence assessment: Evidence is exclusively preclinical (animal models and in vitro). No adequately powered human trials on isolated zingerone for inflammatory conditions have been published. The extrapolation to human therapeutic use remains unverified.

7.4 Neuroprotection and Cognitive Function — Zingerone

A systematic review published in International Journal of Molecular Sciences (2025) synthesized the preclinical literature on zingerone and cognitive disorders. A systematic review was conducted using pre-defined search criteria on Google Scholar, Scopus and Web of Science. The records obtained were screened based on inclusion criteria, and data was extracted from the included studies. Out of the 482 studies that were identified, only 9 studies met the inclusion criteria.

In a study conducted by Rashid et al., zingerone improved learning and memory in cognitively impaired rats administered with lithium and pilocarpine. The improvement in cognitive function exerted by zingerone could be associated with improved neuroinflammatory markers. Recent preclinical studies and systematic reviews have documented the ability of zingerone to prevent neuroinflammation, oxidative stress, and behavioral deficits in models of cognitive impairment, heavy metal toxicity, and mood disorders. For example, it has been found to attenuate cadmium-induced oxidative damage and cognitive decline and also to attenuate inflammation in pain models through modulation of Ca²⁺ signaling and neuronal excitability.

Evidence also supports the anti-allergic potential of zingerone, as shown in a murine asthma model where it alleviated airway inflammation.

Evidence assessment: All neuroprotective and cognitive evidence is preclinical. No human trials have been conducted. The systematic review encompassed only 9 qualifying studies from 482 identified records, indicating the field is nascent and cautious interpretation is warranted.

7.5 Anti-inflammatory and Antinociceptive Activity — Gingerols and Shogaols

These compounds exhibit anti-inflammatory actions by inhibiting COX and LOX pathways, similar to NSAIDs but milder. The dual inhibition of cyclooxygenase and lipoxygenase pathways distinguishes ginger's phenyl alkyl ketones from conventional NSAIDs, which typically inhibit only cyclooxygenase. Ginger (Zingiber officinale) supplements are being promoted for arthritis treatment in western societies based on ginger's traditional use as an anti-inflammatory in Chinese and Ayurvedic medicine. However, scientific evidence of ginger's antiarthritic effects is sparse, and its bioactive joint-protective components have not been identified.

Ginger and ginger extracts were reported to have numerous effects, such as those on diabetes and metabolic syndrome, cholesterol levels and lipid metabolism, and inflammation, revealed by epidemiological studies.

Evidence assessment: Clinical evidence for ginger extracts (which contain gingerols, shogaols, and zingerone collectively) in nausea and arthritis is more developed than for isolated phenyl alkyl ketones. However, attributing effects to any single phenyl alkyl ketone compound in a human clinical context requires further isolation studies.

7.6 Anti-cancer Properties — Preclinical Only

In cultured cell studies and experiments with animals, ginger's pungent principles (gingerols, shogaols, paradols, and zingerone) have proven to possess anti-carcinogenic properties that may be both chemopreventive and chemotherapeutic. These "cancer preventive activities are supposed to be mainly due to free radical scavenging, antioxidant pathways, alteration of gene expressions, and induction of apoptosis, all of which contribute towards decrease in tumor initiation, promotion, and progression." 6-Shogaol damaged microtubules of the cancer cells, halting their reproduction and thus reducing their ability to reproduce.

Zingerone also suppresses matrix metalloproteinase-2 (MMP-2) and MMP-9 during tumor progression, showing its anti-angiogenic activity.

Evidence assessment: All anti-cancer evidence is in vitro or animal-derived. No human interventional studies on isolated phenyl alkyl ketones for cancer prevention or treatment have been published. These findings are preclinical and exploratory only.

7.7 Phytoestrogenic Effects — Curcuma comosa Diarylheptanoids

The estrogenic activity of three active naturally occurring diarylheptanoids from Curcuma comosa was characterized both in vitro and in vivo. All diarylheptanoids up-regulated estrogen-responsive genes in estrogen-responsive breast cancer cells (MCF-7). The in vivo component used a uterotrophic assay in mice, supporting estrogen receptor–mediated mechanisms. No human clinical trials have been conducted on these specific diarylheptanoids.

Evidence assessment: Limited to in vitro and animal evidence. The phytoestrogenic activity in humans is uncharacterized and unquantified.

8. Body Systems and Health Areas Associated with Phenyl Alkyl Ketones

Adipose tissue and metabolic health: Raspberry ketone's proposed effects on adiponectin secretion, lipolysis, and fatty acid oxidation; zingerone's AMPK-activating properties.
Gastrointestinal system: Ginger phenyl alkyl ketones are classically associated with gastroprotective, anti-emetic, and digestive-stimulant activities within traditional medicine frameworks.
Immune and inflammatory pathways: NF-κB, MAPK, COX, and LOX inhibition by zingerone, gingerols, and shogaols.
Central nervous system: Preclinical evidence for neuroprotection, reduction of neuroinflammation, and modulation of serotonin and dopamine systems by zingerone.
Dermatology and hair: Topical raspberry ketone and sensory-neuron-mediated IGF-I induction in skin.
Endocrine system: Diarylheptanoids from Curcuma comosa as phytoestrogens; adiponectin modulation by raspberry ketone.
Cardiovascular system: Ginger and ginger extracts were reported to have numerous effects on cholesterol levels and lipid metabolism. Animal data also suggest effects of raspberry ketone on hemodynamic parameters, though the direction and magnitude in humans are unknown.

9. Dosage Forms and Reported Dosages

9.1 Raspberry Ketone

The U.S. Food and Drug Administration first categorized raspberry ketones as a "Generally Recognized as Safe" (GRAS) food additive in the 1960s. However, GRAS status is given under the assumption that a person will consume less than two milligrams of raspberry ketone a day. Most weight loss supplements pack far more raspberry ketone into their products. Raspberry ketone is not well studied at concentrations used in supplements — which can range from 50 to 250 milligrams per serving.

Raspberry ketone has been qualified as a "Generally Recognized As Safe" (GRAS) flavoring agent and has been widely used. In the single human multi-ingredient study, an eight-week study using a preparation containing raspberry ketone (METABO) administered as 2 capsules at breakfast and 2 capsules at lunchtime was used as a safe and effective adjunct to an eight-week diet and exercise weight loss program by augmenting improvements in body composition, waist and hip girth. The exact dose of raspberry ketone within that preparation was not isolated.

In the animal study by Morimoto et al. (2005), mice were fed a high-fat diet including 0.5, 1, or 2% of RK for 10 weeks. In the Rutgers mouse study by Kshatriya et al. (2020): male and female C57BL/6J mice were administered a daily oral gavage of RK 200 mg/kg, RK 400 mg/kg, or vehicle for 14 days. Mice were placed on a high-fat diet (45% fat) or low-fat diet (10% fat). RK 200 mg/kg had a differential influence on meal patterns in males and females. In contrast, RK 400 mg/kg reduced body weight gain, open-field total distance travelled, hemodynamic measures (i.e., reduced systolic blood pressure, diastolic BP and mean BP), and increased nocturnal satiety ratios in males and females.

For the topical hair-growth application: topical application of 0.01% RK was used in both the mouse and human arms of the Harada et al. (2008) study, with the human arm applying 0.01% RK to the scalp and facial skin.

The appropriate dose of raspberry ketone depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for raspberry ketone.

9.2 Zingerone

In the animal carrageenan inflammation model, paw edema was induced in rats and different doses of zingerone (10, 20, and 40 mg/kg) were administered intraperitoneally. No established human dose for isolated zingerone as a dietary supplement exists in the peer-reviewed literature.

9.3 Ginger (as a standardized extract)

Human clinical research on ginger-derived phenyl alkyl ketones generally uses whole ginger root preparations or standardized extracts rather than isolated compounds. Clinical doses reported in ginger research range widely; however, no specific dosage for isolated gingerol, shogaol, or zingerone in humans has been established from rigorous clinical evidence.

9.4 Common Commercial Forms

Raspberry ketone: oral capsules and tablets (marketed doses typically 100–500 mg per serving); topical creams and scalp solutions (0.01% in published research).
Ginger phenyl alkyl ketones: standardized ginger root powder or extract capsules; ginger essential oil; dried rhizome; fresh rhizome; ginger tea.
Diarylheptanoids: most commonly encountered as part of curcumin/turmeric extracts or whole-plant preparations rather than as isolated diarylheptanoid supplements.

10. Safety Considerations and Drug Interactions

10.1 Raspberry Ketone — GRAS Status and Stimulant Concerns

There isn't enough reliable information available to know if taking raspberry ketone alone is safe. There are some concerns about the safety of raspberry ketone because it is chemically related to a stimulant called synephrine. Therefore, it is possible that raspberry ketone might cause feelings of jitteriness, increase blood pressure, or rapid heartbeat. In one report, someone who took raspberry ketone described feelings of being shaky and a pounding heartbeat (palpitations).

The FDA classifies raspberry ketones as Generally Recognized as Safe (GRAS) when used as a food additive but not for supplements, indicating a need for caution and without science-backed recommended dosages; due to limited human studies, suggested amounts range from 100 to 400 mg, taken once or twice daily.

10.2 Drug Interactions

Warfarin: Warfarin (Coumadin) is used to thin the blood and prevent blood clots. There has been one report of a person taking warfarin (Coumadin) who also took raspberry ketone. In this person warfarin did not work as well after raspberry ketone was taken. The dose of warfarin had to be increased in order to maintain the effect of warfarin and prevent blood clots. This case report, while a single observation, suggests that raspberry ketone may interfere with anticoagulant therapy.

Stimulant medications: Stimulants, such as amphetamines and cocaine, speed up the nervous system. By speeding up the nervous system, stimulant medications can increase blood pressure and speed up the heartbeat. Raspberry ketone might also speed up the nervous system. Taking raspberry ketone along with stimulant drugs might cause serious problems including increased heart rate and high blood pressure.

Diabetes medications: Raspberry ketone may lower blood sugar levels. So, people taking drugs for diabetes should be monitored closely by their healthcare team.

Other medications: Raspberry ketone may also cause changes in body fat and weight, changes in inflammation, heart palpitations and shakiness. Raspberry ketone may also interact with medicines, such as those that regulate heart rate and cholesterol, and hormones.

10.3 Pregnancy and Lactation

There is not enough reliable information about the safety of taking raspberry ketone if you are pregnant or breastfeeding. Stay on the safe side and avoid use. Because of the known smooth-muscle contractility action of red raspberry, pregnant women should not use this product.

10.4 Safety of Supplement-Level Doses vs. Food-Level Doses

A critical distinction exists between the minuscule food-additive amounts of raspberry ketone (GRAS-designated for <2 mg/day) and the doses marketed in supplements (50–500 mg/serving). Raspberry ketone's presumed activity as an anti-obesity or skin-whitening agent drew consumer interest, although a potential toxicity of this compound for humans has not yet been clarified. There is no clinical data on potential drug interactions with raspberry ketones. Researchers have not yet conducted sufficient research to know how raspberry ketones might interact with other drugs.

10.5 Zingerone Safety

Zingerone at food levels (as a natural constituent of cooked ginger) is generally considered safe through centuries of dietary use. Strong radioprotective properties of zingerone are demonstrated against radiation-induced toxicity in preclinical models, suggesting a generally favorable safety profile at studied doses. However, systematic human safety studies for isolated zingerone as a supplement have not been published. An extensive overview of zingerone's phytochemistry, safety, metabolism, toxicity, bioavailability, and its potential as a promising candidate for drug development indicates that detailed pharmacological characterization is ongoing but not yet complete.

11. Summary of Evidence Strength

The following summarizes the evidence quality for the principal health claims associated with phenyl alkyl ketones as dietary supplements:

Weight management (oral raspberry ketone): Very weak. Animal and in vitro data support plausible mechanisms. The single human study used a multi-ingredient product, making isolated attribution impossible. No high-quality human RCT has demonstrated efficacy for oral RK alone.
Hair growth and skin elasticity (topical raspberry ketone): Preliminary. One small human study (n=10) showed a positive signal at 5 months with 0.01% topical application. No independent replication exists.
Anti-inflammatory activity (zingerone, gingerols, shogaols): Moderate preclinical; weak clinical. Robust in vitro and animal data. Ginger extract clinical trials suggest anti-inflammatory effects, but these cannot be definitively attributed to individual phenyl alkyl ketone constituents.
Neuroprotection and cognitive function (zingerone): Preclinical only. Nine qualifying animal studies in a 2025 systematic review show consistent signals; no human data exist.
Anti-cancer properties: Preclinical only. In vitro and animal evidence; no clinical translation.
Phytoestrogenic effects (diarylheptanoids): Preclinical only. In vitro and animal data; no human trials.